期刊文献+

核因子-κB及P糖蛋白在人骨肉瘤中的表达及意义 被引量:5

Expression and significance of NF-κB and P-gp in human osteosarcoma
原文传递
导出
摘要 目的探讨核因子-κB(NF-κB)及P糖蛋白(P-gp)在骨肉瘤组织中的表达及其临床意义。方法选取2009年1月至2016年12月间武汉大学人民医院收治的经术前穿刺组织学病理诊断的26例骨肉瘤患者的肿瘤组织标本,采用免疫组化法(S-P法)及West Blot法测定NF-κB及P-gp在诱导化疗后骨肉瘤组织中的表达。比较化疗原发耐药组(6例)和化疗有效组(20例)中NF-κB及P-gp表达的差异,并分析其与化疗耐药的相关性。结果化疗耐药组骨肉瘤组织的p-gp阳性表达率为83.3%,显著高于化疗有效组p-gp的阳性表达率35.0%,差异有统计学意义(P<0.01)。化疗耐药组骨肉瘤组织NF-κB阳性表达率为83.3%,显著高于化疗有效组45.0%,差异有统计学意义(P<0.01)。相关因素分析表明,NF-κB及P-gp在骨肉瘤组织中的表达与其耐药有高度相关性,NF-κB P65的表达与P-gp表达呈正相关,差异有统计学意义(P<0.05)。结论 NF-κB及P-gp在骨肉瘤原发耐药组中高表达,可能是骨肉瘤原发耐药的发生机制之一。 Objective To investigate the expression of nuclear factor-κB( NF-κB) and P-glycoprotein( P-gp) in osteosarcoma and its clinical significance. Methods Tumor tissue specimens were collected from 26 patients with osteosarcoma treated at People's Hospital of Wuhan University between January 2009 and December 2016. Immunohistochemical( S-P) and West Blot method were used to determine the expression of NF-κB and P-gp in osteosarcoma after induction chemotherapy. The difference in the expression of NF-κB and P-gp was compared between the primary drug-resistance group( 6 patients) and the chemotherapy effecacy group( 20 patients),and the correlation with chemotherapy-resistance was analyzed. Results The positive expression rate of P-gp in osteosarcoma tissues was 83. 3% in the chemotherapy-resistance group,which was significantly higher than 35. 0% of the chemotherapy efficacy group( P〈0. 01). The positive expression rate of NF-κB in osteosarcoma tissues was 83. 3% chemotherapy resistant group,which was significantly higher than 45. 0% of chemotherapy efficacy group( P〈0. 01). Correlation analysis showed that the expression of NF-κB and P-gp in osteosarcoma tissues was highly correlated with drug resistance. The expression of NF-κB P65 was positively correlated with the expression of P-gp( P〈0. 05). Conclusion NF-κB and P-gp are highly expressed in the primary resistance group of osteosarcoma,which may be one of the mechanisms of primary resistance of osteosarcoma.
出处 《中国肿瘤临床与康复》 2017年第11期1286-1289,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 国家自然科学基金项目(81341078) 武汉大学青年教师项目(2042014kfo1482)
关键词 骨肉瘤 核因子-ΚB P糖蛋白 Osteosarcoma Nnuclear factor-κB P-gp
  • 相关文献

参考文献5

二级参考文献33

  • 1JingLIU AnningLIN.Role of JNK activation in apoptosis:Adouble-edged sword[J].Cell Research,2005,15(1):36-42. 被引量:76
  • 2李珊珊.信号转导通路与食管癌[J].中华病理学杂志,2007,36(6):366-369. 被引量:6
  • 3Karin M. Nuclear factor-kappa B in cancer development and pro- gression [ J ]. Nature, 2006, 441:431-436.
  • 4Goswami B, Rajappa M, Sharma M, et al. Inflammation : its role and inter play in the development of cancer, with special focus on gynecological malignancies [ J ]. Int J Gynecol Cancer, 2008, 18,591-599.
  • 5Hatata T, Higaki K, Tatebe S, et al. Immunohistochemical study of nuclear factor-KB expression in esophageal squamous cellcar- cinoma:prognostic significance and sensitivity to treatment with 5-FU [J]. Dis Esophagus, 2012, 31 : 1442-2050.
  • 6Hatata T, Higaki K, Nanba E, et al. Inhibition of nuclear factor- KB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines[ J]. Oncol Rep, 2011, 26:659-664.
  • 7Bromberg J, Wang TC. Inflammation and Cancer: IL-6 and STAT3 Complete the Link[J]. Cancer Cell, 2009, 15:79-80.
  • 8Lukaszewicz-Zaja c M, Mroczko B, Koziowski M, et al. Higher im- portance of interleukin 6 than classic tumor markers in the diag- nosis of esophageal cancer patients [ J ]. Dis Esophagus, 2012, 25:242-249.
  • 9Karashima T, Sweeney P, Kamat A, et al. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder can- certhrough the regulation of interleukin-8 [J]. Clin Cancer Res, 2003, 9:2786-2797.
  • 10Ritter J, Bielack SS. OsteosarcomaLJ].Ann Oncol, 2010, 21(7):320-325.

共引文献76

同被引文献57

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部